#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	3082	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2549	356.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1580	1580	C	445	C,T,A	401,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4772	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4194	341.0	0	.	n	.	0	T695C	SNP	695	695	T	1348	1348	C	324	C	290	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4772	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4194	341.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1990	1990	A	402	A,G,C	366,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4772	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4194	341.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2624	2624	C	478	C,A,T	433,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4772	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4194	341.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3250	3250	T	392	T,G	351,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4772	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4194	341.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2698	2698	A	501	A,C	446,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	432	folP	852	852	100.0	folP.l6.c17.ctg.1	2170	59.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1377	1379	AGC	90;90;90	A;G;C	79;78;79	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1038	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4078	76.3	1	SNP	p	S91F	0	.	.	271	273	TCC	969	971	TCC	88;88;88	T;C;C	77;80;80	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1038	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4078	76.3	1	SNP	p	D95N	0	.	.	283	285	GAC	981	983	GAC	84;84;84	G;A;C	78;78;76	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1038	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4078	76.3	1	SNP	p	D95G	0	.	.	283	285	GAC	981	983	GAC	84;84;84	G;A;C	78;78;76	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	436	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1830	71.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	280	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1555	54.1	0	.	n	.	0	C187G	SNP	187	187	C	893	893	G	97	G	93	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1012	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3430	88.3	1	SNP	p	D86N	0	.	.	256	258	GAC	882	884	GAC	91;90;89	G;A;C	81;78;84	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1012	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3430	88.3	1	SNP	p	S87R	0	.	.	259	261	AGT	885	887	AGT	90;90;91	A;G;T	80;81;82	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1012	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3430	88.3	1	SNP	p	S87I	0	.	.	259	261	AGT	885	887	AGT	90;90;91	A;G;T	80;81;82	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1012	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3430	88.3	1	SNP	p	S87W	0	.	.	259	261	AGT	885	887	AGT	90;90;91	A;G;T	80;81;82	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1012	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3430	88.3	1	SNP	p	S88P	0	.	.	262	264	TCC	888	890	TCC	91;92;92	T;C;C	83;84;85	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	830	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3104	80.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1780	1782	GGC	93;93;92	G;G;C	83;84;84	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1621	1623	GCA	94;93;93	G;C;A	88;84;87	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1624	1626	ATC	93;92;93	A,C;T;C,A	87,1;83;85,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1636	1638	GTG	94;94;94	G;T,C;G	87;83,1;85	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1636	1638	GTG	94;94;94	G;T,C;G	87;83,1;85	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2140	2142	ACC	82;83;84	A,C;C;C	73,1;72;73	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2194	2196	GCG	77;77;77	G;C;G	71;58;63	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2194	2196	GCG	77;77;77	G;C;G	71;58;63	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2317	2319	GGC	85;85;85	G;G;C	72;73;73	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2326	2328	GGC	83;82;81	G;G;C	68;70;71	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3037	70.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2344	2346	CCG	85;85;84	C,T;C;G,A	67,1;72;72,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1066	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3600	88.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1865	1867	CTG	111;113;112	C,G;T,C;G	95,1;97,1;101	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	486	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2254	64.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	796	796	C	83	C	77	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	178	90.66	porB1a.l15.c17.ctg.1	1312	20.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1159	1161	AAT	9;9;9	A;A;T	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	178	90.66	porB1a.l15.c17.ctg.1	1312	20.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1162	1164	AAT	9;9;9	A;A;T	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	178	90.66	porB1a.l15.c17.ctg.1	1312	20.5	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1174	1176	GTT	8;8;8	G;T;T	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	178	90.66	porB1a.l15.c17.ctg.1	1312	20.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1186	1188	GCA	8;8;8	G;C;A	8;7;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	178	90.66	porB1a.l15.c17.ctg.1	1312	20.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1209	1211	GTA	8;8;8	G;T;A	7;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	92	porB1a	984	178	90.66	porB1a.l15.c17.ctg.1	1312	20.5	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1218	1218	A	8	A	8	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	739	741	GAA	106;106;106	G;A;A	98;99;96	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	S46D	NONSYN	136	138	AGC	763	765	GAC	105;103;105	G;A;C	97;96;98	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	769	771	GGA	104;104;105	G;G;A	99;96;98	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	886	888	GCT	128;128;129	G;C;T	110;112;109	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	892	894	AGC	123;124;124	A;G;C	111;109;111	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	984	985	CG	129;129	C;G,C	117;118,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	987	989	CAG	131;130;130	C;A;G	122;121;120	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	991	993	AAA	126;126;126	A;A;A	118;117;115	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	1054	1056	GAA	135;134;134	G;A;A	124;121;122	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1078	1080	GCA	134;134;134	G,T,C;C,A,G;A	122,1,1;120,1,1;124	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1186	1188	CGA	129;130;131	C;G;A	117;115;113	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1270	1272	ACT	141;141;141	A;C;T	125;125;117	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1273	1275	CAT	141;142;141	C,A;A;T	122,1;123;121	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1279	1281	ATG	141;141;140	A,G;T,G;G	125,1;124,1;124	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	.	MULTIPLE	766	767	AC	1393	1395	GCA	133;132;131	G;C,A;A	123;122,1;124	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	W257R	NONSYN	769	771	TGG	1397	1399	CGG	130;131;131	C,G;G;G,A	120,1;125;122,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	0	.	p	.	0	S258fs	FSHIFT	772	772	A	1400	1400	A	131	A	119	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	1	SNP	p	G120K	1	.	.	358	360	AAG	984	986	CGG	129;129;129	C;G,C;G	117;118,1;118	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	1	SNP	p	D121N	0	.	.	361	363	GAC	987	990	CGC	131;130;129	C;G;C	122;120;119	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	620	porB1b	1047	1047	96.47	porB1b.l15.c4.ctg.1	2101	87.6	1	SNP	p	A121D	1	.	.	361	363	GAC	987	990	CGC	131;130;129	C;G;C	122;120;119	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1822	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5548	98.6	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2396	2398	AAT	94;94;94	A;A;T	85;85;87	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	338	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1621	62.5	1	SNP	p	V57M	1	.	.	169	171	ATG	833	835	ATG	128;128;128	A;T;G	120;120;120	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
